{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-025349","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2022-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.068267+00:00","generated_at":"2026-06-23T08:04:11.058312+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Oncology Institute appoints Mark Pacala and Gabe Ling to Board, expanding to 9 members","bullets":["Mark Pacala brings >30 yrs healthcare management/PE experience; former CEO of Forum Group and American Whole Health.","Gabe Ling is co-founder of M33 Growth, a principal stockholder; previously partner at General Catalyst.","Appointments effective immediately; new directors will serve until 2023 Annual Meeting.","Neither director will serve on any committee; Pacala determined independent; Ling affiliated with M33.","Compensation will follow standard non-employee director policy as disclosed in 10-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-025349","json":"https://secwatch.observer/filing/0001628280-22-025349.json","markdown":"https://secwatch.observer/filing/0001628280-22-025349.md","text":"https://secwatch.observer/filing/0001628280-22-025349.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022025349/0001628280-22-025349-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022025349/toi-20220921.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T08:04:11.058312+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4c84676949","claim":"Mark Pacala was appointed as Director at Oncology Institute, Inc..","evidence_excerpt":"the Board appointed Mr. Mark Pacala and Mr. Gabriel Ling to the Board, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022025349/0001628280-22-025349-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"929b5d7437","claim":"Gabriel Ling was appointed as Director at Oncology Institute, Inc..","evidence_excerpt":"the Board appointed Mr. Mark Pacala and Mr. Gabriel Ling to the Board, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022025349/0001628280-22-025349-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}